Call of Cthulhu: Delta Green


March 25, 2013

Dawn_Biozyme.pngWASHINGTON. D.C. (REUTERS) The strange bad luck of the pharmaceutical company Dawn Biozyme continued today, as legislators effectively put a halt to all business operations. This investigation by the FDA comes as further shock to a company which earlier this year sustained the explosion of its headquarters, the grisly robbery/murder of one of its key scientific team, Albert Finely and his wife, and the suicide of its chairman and CEO, James Corazini. The firm, once valued at $400 million, has had all assets frozen and all employees subpoenaed. Sources inside the investigation suggest the firm was engaged in illegal research into genetic crop engineering.



I'm sorry, but we no longer support this web browser. Please upgrade your browser or install Chrome or Firefox to enjoy the full functionality of this site.